"AssociationType"	"ChemShowNames"	"DOClass"	"Disease"	"DiseaseClass"	"Gene"	"GeneDPI"	"GeneDSI"	"GeneFullName"	"GenePLI"	"HPOClass"	"Journal"	"NumDiseasesAssociatedToGene"	"NumGenesDisease"	"NumVariantsAssociatedToGene"	"NumVariantsDisease"	"OriginalDB"	"PMID"	"PathwayIDs"	"PathwayNames"	"ProteinClass"	"ScoreGDA"	"SemanticType"	"Sentence"	"Type"	"UnitProt"	"Year"	"chemUMLSCUIs"	"chemical_effect"	"diseaseUMLSCUI"	"geneEnsemblIDs"	"geneNcbiID"	"geneNcbiType"	"reference"	"reference_type"
"CausalorOrContributing"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"FLT3"	"0.83"	"0.44"	"fms related receptor tyrosine kinase 3"	"0.99725"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Cancer research communications"	"399"	"4476"	"62"	"7707"	"TEXTMINING_MODELS"	"39007347"	"R-HSA-162582,R-HSA-1643685,R-HSA-168256"	"Signal Transduction,Disease,Immune System"	"Kinase"	"1.0"	"Neoplastic Process (T191)"	"Targeting either <span class='gene' en_id='2322'>FLT3</span> or CD99 using FLT3-A192 or CD99-A192 led to <span class='disease' en_id='C0023467'>AML</span> cell death and reduced leukemia burden in <span class='disease' en_id='C0023467'>AML</span> mouse models."	"disease"	"P36888"	"2024"	""	""	"C0023467"	"ENSG00000122025"	"2322"	"protein-coding"	"39007347"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"FLT3"	"0.83"	"0.44"	"fms related receptor tyrosine kinase 3"	"0.99725"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Leukemia"	"399"	"4476"	"62"	"7707"	"TEXTMINING_MODELS"	"38182819"	"R-HSA-162582,R-HSA-1643685,R-HSA-168256"	"Signal Transduction,Disease,Immune System"	"Kinase"	"1.0"	"Neoplastic Process (T191)"	"Internal tandem duplication mutations in <span class='gene' en_id='2322'>fms-like tyrosine kinase 3</span> (FLT3-ITD) are recurrent in <span class='disease' en_id='C0023467'>acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>) and increase the risk of relapse."	"disease"	"P36888"	"2024"	""	""	"C0023467"	"ENSG00000122025"	"2322"	"protein-coding"	"38182819"	"PMID"
"AlteredExpression"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"GATA2"	"0.91"	"0.43"	"GATA binding protein 2"	"0.99993"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Rinsho ketsueki] The Japanese journal of clinical hematology"	"472"	"4476"	"581"	"7707"	"TEXTMINING_MODELS"	"39358289"	"R-HSA-109582,R-HSA-1266738,R-HSA-74160"	"Hemostasis,Developmental Biology,Gene expression (Transcription)"	""	"1.0"	"Neoplastic Process (T191)"	"Similarly, <span class='gene' en_id='2624'>GATA2 factor</span> expression is dynamic in the hematopoietic hierarchy, and dysfunction of <span class='gene' en_id='2624'>GATA2 factor</span> contributes <span class='negation_marker' en_id=''>not</span> only to dysfunction of the myeloid and lymphoid lineages but also to the development of diverse hematopoietic neoplasms such as myelodysplastic syndromes, <span class='disease' en_id='C0023467'>acute myeloid leukemia</span>, and myeloproliferative neoplasms."	"disease"	"P23769"	"2024"	""	""	"C0023467"	"ENSG00000179348"	"2624"	"protein-coding"	"39358289"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"TP53"	"0.96"	"0.26"	"tumor protein p53"	"0.99795"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Blood cancer journal"	"2880"	"4476"	"1281"	"7707"	"TEXTMINING_MODELS"	"38177095"	"R-HSA-109582,R-HSA-1266738,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-5357801,R-HSA-73894,R-HSA-74160,R-HSA-8953897"	"Hemostasis,Developmental Biology,Signal Transduction,Cell Cycle,Disease,Immune System,Metabolism of proteins,Programmed Cell Death,DNA Repair,Gene expression (Transcription),Cellular responses to stimuli"	"Transcription factor"	"1.0"	"Neoplastic Process (T191)"	"Classical myeloproliferative neoplasms (MPNs) are characterized by the proliferation of myeloid cells and the risk of transformation into myelofibrosis or <span class='disease' en_id='C0023467'>acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>) and <span class='gene' en_id='7157'>TP53</span> mutations in MPN patients are linked to <span class='disease' en_id='C0023467'>AML</span>."	"disease"	"P04637,A0A087WT22,H2EHT1,A0A087X1Q1,K7PPA8,A0A087WXZ1,Q53GA5"	"2024"	""	""	"C0023467"	"ENSG00000141510"	"7157"	"protein-coding"	"38177095"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"TP53"	"0.96"	"0.26"	"tumor protein p53"	"0.99795"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Cell reports. Medicine"	"2880"	"4476"	"1281"	"7707"	"TEXTMINING_MODELS"	"38733986"	"R-HSA-109582,R-HSA-1266738,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-5357801,R-HSA-73894,R-HSA-74160,R-HSA-8953897"	"Hemostasis,Developmental Biology,Signal Transduction,Cell Cycle,Disease,Immune System,Metabolism of proteins,Programmed Cell Death,DNA Repair,Gene expression (Transcription),Cellular responses to stimuli"	"Transcription factor"	"1.0"	"Neoplastic Process (T191)"	"One model induces <span class='gene' en_id='7157'>mutant p53</span> and Mdm2 haploinsufficiency in early development, showing the role of Mdm2 in myeloid-biased hematopoiesis and <span class='disease' en_id='C0023467'>AML</span> predisposition, independent of p53."	"disease"	"P04637,A0A087WT22,H2EHT1,A0A087X1Q1,K7PPA8,A0A087WXZ1,Q53GA5"	"2024"	""	""	"C0023467"	"ENSG00000141510"	"7157"	"protein-coding"	"38733986"	"PMID"
"CausalorOrContributing"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"NPM1"	"0.91"	"0.43"	"nucleophosmin 1"	"0.99647"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Leukemia"	"499"	"4476"	"23"	"7707"	"TEXTMINING_MODELS"	"39443736"	"R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160"	"Cell Cycle,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription)"	"Chaperone"	"1.0"	"Neoplastic Process (T191)"	"<span class='gene' en_id='4869'>NPM1</span>::MLF1 is present in both the nucleus and cytoplasm and occasionally induces <span class='disease' en_id='C0023467'>AML</span> in the mouse transplantation assay."	"disease"	"A0A0S2Z491,P06748,A0A140VJQ2,A0A0S2Z4G7"	"2024"	""	""	"C0023467"	"ENSG00000181163"	"4869"	"protein-coding"	"39443736"	"PMID"
"AlteredExpression"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"CEBPA"	"0.91"	"0.45"	"CCAAT enhancer binding protein alpha"	"0.26045"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Biochimica et biophysica acta. Gene regulatory mechanisms"	"380"	"4476"	"378"	"7707"	"TEXTMINING_MODELS"	"38008244"	"R-HSA-1266738,R-HSA-74160"	"Developmental Biology,Gene expression (Transcription)"	"Transcription factor"	"1.0"	"Neoplastic Process (T191)"	"Notably, RNA-sequencing revealed several mRNAs encoding key transcription factors involved in the regulation of myeloid differentiation as targets of hnRNP K. We showed that specific sequence motifs confer the interaction of SPI1 and <span class='gene' en_id='1050'>CEBPA</span> 5' and 3'UTRs with hnRNP K. The siRNA mediated reduction of hnRNP K in human <span class='disease' en_id='C0023467'>AML</span> cells resulted in an increase of PU.1 and <span class='gene' en_id='1050'>C/EBPα</span> that is most pronounced for the p30 isoform."	"disease"	"P49715"	"2024"	""	""	"C0023467"	"ENSG00000245848"	"1050"	"protein-coding"	"38008244"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"FLT3"	"0.83"	"0.44"	"fms related receptor tyrosine kinase 3"	"0.99725"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Drug development research"	"399"	"4476"	"62"	"7707"	"TEXTMINING_MODELS"	"38349260"	"R-HSA-162582,R-HSA-1643685,R-HSA-168256"	"Signal Transduction,Disease,Immune System"	"Kinase"	"1.0"	"Neoplastic Process (T191)"	"<span class='disease' en_id='C0023467'>Acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>) patients with <span class='gene' en_id='2322'>FLT3</span> internal tandem duplication (FLT3-ITD) and DNA methyltransferase 3A (DNMT3A) R882 double mutations had a worse prognosis compared with <span class='disease' en_id='C0023467'>AML</span> with FLT3-ITD or DNMT3A R882 single mutation."	"disease"	"P36888"	"2024"	""	""	"C0023467"	"ENSG00000122025"	"2322"	"protein-coding"	"38349260"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"FLT3"	"0.83"	"0.44"	"fms related receptor tyrosine kinase 3"	"0.99725"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Journal of biomolecular structure & dynamics"	"399"	"4476"	"62"	"7707"	"TEXTMINING_MODELS"	"36995071"	"R-HSA-162582,R-HSA-1643685,R-HSA-168256"	"Signal Transduction,Disease,Immune System"	"Kinase"	"1.0"	"Neoplastic Process (T191)"	"Around 30% of <span class='disease' en_id='C0023467'>acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>) patients have triggering mutations in Feline McDonough Sarcoma (FMS)-like tyrosine kinase 3 (<span class='gene' en_id='2322'>FLT3</span>), which has been suggested as a possible therapeutic candidate for <span class='disease' en_id='C0023467'>AML</span> therapy."	"disease"	"P36888"	"2024"	""	""	"C0023467"	"ENSG00000122025"	"2322"	"protein-coding"	"36995071"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"NPM1"	"0.91"	"0.43"	"nucleophosmin 1"	"0.99647"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Nature immunology"	"499"	"4476"	"23"	"7707"	"TEXTMINING_MODELS"	"39103576"	"R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160"	"Cell Cycle,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription)"	"Chaperone"	"1.0"	"Neoplastic Process (T191)"	"<span class='gene' en_id='4869'>Nucleophosmin 1</span> (<span class='gene' en_id='4869'>NPM1</span>) is commonly mutated in myelodysplastic syndrome (MDS) and <span class='disease' en_id='C0023467'>acute myeloid leukemia</span>."	"disease"	"A0A0S2Z491,P06748,A0A140VJQ2,A0A0S2Z4G7"	"2024"	""	""	"C0023467"	"ENSG00000181163"	"4869"	"protein-coding"	"39103576"	"PMID"
"AlteredExpression"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"DNMT3A"	"0.96"	"0.4"	"DNA methyltransferase 3 alpha"	"2.8201E-146"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Science advances"	"711"	"4476"	"161"	"7707"	"TEXTMINING_MODELS"	"38295174"	"R-HSA-1643685,R-HSA-392499,R-HSA-4839726,R-HSA-74160"	"Disease,Metabolism of proteins,Chromatin organization,Gene expression (Transcription)"	""	"1.0"	"Neoplastic Process (T191)"	"Overexpression of DNMT3L (which is minimally expressed in <span class='disease' en_id='C0023467'>AML</span> cells) also corrects the hypomethylation phenotype of Dnmt3aR878H/+ marrow, probably by augmenting the activity of WT <span class='gene' en_id='1788'>DNMT3A</span> encoded by the residual WT allele."	"disease"	"F8WE91,A0A0C4DG02,Q59HC6,Q9Y6K1"	"2024"	""	""	"C0023467"	"ENSG00000119772"	"1788"	"protein-coding"	"38295174"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"KIT"	"0.91"	"0.31"	"KIT proto-oncogene, receptor tyrosine kinase"	"1.0"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Molecular cancer research : MCR"	"1573"	"4476"	"978"	"7707"	"TEXTMINING_MODELS"	"37756563"	"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-74160"	"Developmental Biology,Signal Transduction,Disease,Gene expression (Transcription)"	"Kinase"	"1.0"	"Neoplastic Process (T191)"	"Our studies uncover a novel mechanism that fine-tunes oncogenic <span class='gene' en_id='3815'>KIT</span> signaling in leukemia cells and will likely identify PRL2 as a novel therapeutic target in <span class='disease' en_id='C0023467'>AML</span> with <span class='gene' en_id='3815'>KIT</span> mutations."	"disease"	"P10721"	"2024"	""	""	"C0023467"	"ENSG00000157404"	"3815"	"protein-coding"	"37756563"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"NPM1"	"0.91"	"0.43"	"nucleophosmin 1"	"0.99647"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"JACS Au"	"499"	"4476"	"23"	"7707"	"TEXTMINING_MODELS"	"38818079"	"R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-74160"	"Cell Cycle,Disease,Immune System,Metabolism of proteins,Gene expression (Transcription)"	"Chaperone"	"1.0"	"Neoplastic Process (T191)"	"The new <span class='gene' en_id='4869'>NPM1</span> inhibitor triggers apoptosis in <span class='disease' en_id='C0023467'>AML</span> cell lines and primary cells from <span class='disease' en_id='C0023467'>AML</span> patients and reduces tumor infiltration in a mouse model of <span class='disease' en_id='C0023467'>AML</span> with <span class='gene' en_id='4869'>NPM1</span> C+ mutation."	"disease"	"A0A0S2Z491,P06748,A0A140VJQ2,A0A0S2Z4G7"	"2024"	""	""	"C0023467"	"ENSG00000181163"	"4869"	"protein-coding"	"38818079"	"PMID"
"CausalorOrContributing"	"Venetoclax"	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"BCL2"	"0.91"	"0.3"	"BCL2 apoptosis regulator"	"0.98901"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"iScience"	"1777"	"4476"	"45"	"7707"	"TEXTMINING_MODELS"	"38689642"	"R-HSA-1266738,R-HSA-162582,R-HSA-168256,R-HSA-5357801,R-HSA-8953897"	"Developmental Biology,Signal Transduction,Immune System,Programmed Cell Death,Cellular responses to stimuli"	"Signaling"	"1.0"	"Neoplastic Process (T191)"	"FX1-5303 synergizes with the clinically approved <span class='gene' en_id='596'>BCL2</span> inhibitor <span class='chemical' en_id='C4079830'>venetoclax</span> in <span class='disease' en_id='C0023467'>acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>) cell lines and ex vivo patient samples and leads to strong tumor growth inhibition in in vivo mouse xenograft models of multiple myeloma and <span class='disease' en_id='C0023467'>AML</span>."	"disease"	"A0A7I2V3S7,P10415"	"2024"	"C4079830"	"therapeutic"	"C0023467"	"ENSG00000171791"	"596"	"protein-coding"	"38689642"	"PMID"
"CausalorOrContributing"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"CEBPA"	"0.91"	"0.45"	"CCAAT enhancer binding protein alpha"	"0.26045"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Journal of experimental & clinical cancer research : CR"	"380"	"4476"	"378"	"7707"	"TEXTMINING_MODELS"	"38475919"	"R-HSA-1266738,R-HSA-74160"	"Developmental Biology,Gene expression (Transcription)"	"Transcription factor"	"1.0"	"Neoplastic Process (T191)"	"Our results indicate that <span class='disease' en_id='C0023467'>AML</span> patients with a low <span class='gene' en_id='1050'>C/EBPα</span> p42/p30 ratio (e.g., CEBPAbi) may <span class='negation_marker' en_id=''>not</span> benefit from monotherapy with BCL2 inhibitors."	"disease"	"P49715"	"2024"	""	""	"C0023467"	"ENSG00000245848"	"1050"	"protein-coding"	"38475919"	"PMID"
"AlteredExpression"	"Venetoclax"	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"BCL2"	"0.91"	"0.3"	"BCL2 apoptosis regulator"	"0.98901"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Leukemia"	"1777"	"4476"	"45"	"7707"	"TEXTMINING_MODELS"	"38643304"	"R-HSA-1266738,R-HSA-162582,R-HSA-168256,R-HSA-5357801,R-HSA-8953897"	"Developmental Biology,Signal Transduction,Immune System,Programmed Cell Death,Cellular responses to stimuli"	"Signaling"	"1.0"	"Neoplastic Process (T191)"	"Additionally, mass spectrometry analysis revealed that <span class='chemical' en_id='C4079830'>Venetoclax</span> (<span class='chemical' en_id='C4079830'>VEN</span>), a <span class='gene' en_id='596'>BCL-2</span> inhibitor recently approved by the FDA for <span class='disease' en_id='C0023467'>AML</span> treatment, significantly decreases the intracellular level of methionine in <span class='disease' en_id='C0023467'>AML</span> cells."	"disease"	"A0A7I2V3S7,P10415"	"2024"	"C4079830"	"therapeutic"	"C0023467"	"ENSG00000171791"	"596"	"protein-coding"	"38643304"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"RUNX1"	"0.87"	"0.4"	"RUNX family transcription factor 1"	"0.28954"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Blood cancer journal"	"657"	"4476"	"663"	"7707"	"TEXTMINING_MODELS"	"38316746"	"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-382551,R-HSA-74160"	"Developmental Biology,Signal Transduction,Disease,Transport of small molecules,Gene expression (Transcription)"	"Transcription factor"	"1.0"	"Neoplastic Process (T191)"	"Germline, mono-allelic mutations in <span class='gene' en_id='861'>RUNX1</span> cause familial platelet disorder (RUNX1-FPD) that evolves into myeloid malignancy (FPD-MM): MDS or <span class='disease' en_id='C0023467'>AML</span>."	"disease"	"Q01196"	"2024"	""	""	"C0023467"	"ENSG00000159216"	"861"	"protein-coding"	"38316746"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"TP53"	"0.96"	"0.26"	"tumor protein p53"	"0.99795"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Leukemia"	"2880"	"4476"	"1281"	"7707"	"TEXTMINING_MODELS"	"38937548"	"R-HSA-109582,R-HSA-1266738,R-HSA-162582,R-HSA-1640170,R-HSA-1643685,R-HSA-168256,R-HSA-392499,R-HSA-5357801,R-HSA-73894,R-HSA-74160,R-HSA-8953897"	"Hemostasis,Developmental Biology,Signal Transduction,Cell Cycle,Disease,Immune System,Metabolism of proteins,Programmed Cell Death,DNA Repair,Gene expression (Transcription),Cellular responses to stimuli"	"Transcription factor"	"1.0"	"Neoplastic Process (T191)"	"However, the combined Ddx41 and <span class='gene' en_id='7157'>Trp53</span> mutant mice were prone to developing hematologic malignancies that resemble human myelodysplastic syndrome and <span class='disease' en_id='C0023467'>acute myeloid leukemia</span>."	"disease"	"P04637,A0A087WT22,H2EHT1,A0A087X1Q1,K7PPA8,A0A087WXZ1,Q53GA5"	"2024"	""	""	"C0023467"	"ENSG00000141510"	"7157"	"protein-coding"	"38937548"	"PMID"
"CausalorOrContributing"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"RUNX1"	"0.87"	"0.4"	"RUNX family transcription factor 1"	"0.28954"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Leukemia"	"657"	"4476"	"663"	"7707"	"TEXTMINING_MODELS"	"37838757"	"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-382551,R-HSA-74160"	"Developmental Biology,Signal Transduction,Disease,Transport of small molecules,Gene expression (Transcription)"	"Transcription factor"	"1.0"	"Neoplastic Process (T191)"	"T(8;21)(q22;q22), which generates the <span class='gene' en_id='861'>AML1-ETO fusion</span> oncoprotein, is a common chromosomal abnormality in <span class='disease' en_id='C0023467'>acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>) patients."	"disease"	"Q01196"	"2024"	""	""	"C0023467"	"ENSG00000159216"	"861"	"protein-coding"	"37838757"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"FLT3"	"0.83"	"0.44"	"fms related receptor tyrosine kinase 3"	"0.99725"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"The Journal of clinical investigation"	"399"	"4476"	"62"	"7707"	"TEXTMINING_MODELS"	"38950330"	"R-HSA-162582,R-HSA-1643685,R-HSA-168256"	"Signal Transduction,Disease,Immune System"	"Kinase"	"1.0"	"Neoplastic Process (T191)"	"Despite the high prevalence of <span class='gene' en_id='2322'>FLT3</span> mutations and their clinical significance in <span class='disease' en_id='C0023467'>AML</span>, there are few targeted therapeutic options available."	"disease"	"P36888"	"2024"	""	""	"C0023467"	"ENSG00000122025"	"2322"	"protein-coding"	"38950330"	"PMID"
"CausalorOrContributing"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"BCL2"	"0.91"	"0.3"	"BCL2 apoptosis regulator"	"0.98901"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Biomacromolecules"	"1777"	"4476"	"45"	"7707"	"TEXTMINING_MODELS"	"38869359"	"R-HSA-1266738,R-HSA-162582,R-HSA-168256,R-HSA-5357801,R-HSA-8953897"	"Developmental Biology,Signal Transduction,Immune System,Programmed Cell Death,Cellular responses to stimuli"	"Signaling"	"1.0"	"Neoplastic Process (T191)"	"CXCR4-Mediated Codelivery of FLT3 and <span class='gene' en_id='596'>BCL-2</span> Inhibitors for Enhanced Targeted Combination Therapy of FLT3-ITD <span class='disease' en_id='C0023467'>Acute Myeloid Leukemia</span>."	"disease"	"A0A7I2V3S7,P10415"	"2024"	""	""	"C0023467"	"ENSG00000171791"	"596"	"protein-coding"	"38869359"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"DNMT3A"	"0.96"	"0.4"	"DNA methyltransferase 3 alpha"	"2.8201E-146"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Drug development research"	"711"	"4476"	"161"	"7707"	"TEXTMINING_MODELS"	"38349260"	"R-HSA-1643685,R-HSA-392499,R-HSA-4839726,R-HSA-74160"	"Disease,Metabolism of proteins,Chromatin organization,Gene expression (Transcription)"	""	"1.0"	"Neoplastic Process (T191)"	"<span class='disease' en_id='C0023467'>Acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>) patients with FLT3 internal tandem duplication (FLT3-ITD) and <span class='gene' en_id='1788'>DNA methyltransferase 3A</span> (<span class='gene' en_id='1788'>DNMT3A</span>) R882 double mutations had a worse prognosis compared with <span class='disease' en_id='C0023467'>AML</span> with FLT3-ITD or <span class='gene' en_id='1788'>DNMT3A</span> R882 single mutation."	"disease"	"F8WE91,A0A0C4DG02,Q59HC6,Q9Y6K1"	"2024"	""	""	"C0023467"	"ENSG00000119772"	"1788"	"protein-coding"	"38349260"	"PMID"
"AlteredExpression"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"KMT2A"	"0.91"	"0.43"	"lysine methyltransferase 2A"	"1.0"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Journal of hematology & oncology"	"556"	"4476"	"201"	"7707"	"TEXTMINING_MODELS"	"39380002"	"R-HSA-1266738,R-HSA-4839726,R-HSA-74160"	"Developmental Biology,Chromatin organization,Gene expression (Transcription)"	""	"1.0"	"Neoplastic Process (T191)"	"In contrast, our pharmacologic and genetic results indicate that the catalytic activity of KAT6A plays a more limited role in KMT2Ar leukemogenicity, while targeting the whole KAT6A protein dramatically affects leukemic potential in murine <span class='gene' en_id='4297'>KMT2A</span>::MLLT3 <span class='disease' en_id='C0023467'>AML</span>."	"disease"	"E9PR05,Q03164"	"2024"	""	""	"C0023467"	"ENSG00000118058"	"4297"	"protein-coding"	"39380002"	"PMID"
"CausalorOrContributing"	"decitabine"	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"ASXL1"	"0.91"	"0.45"	"ASXL transcriptional regulator 1"	"1.5219E-16"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Cancer letters"	"501"	"4476"	"79"	"7707"	"TEXTMINING_MODELS"	"38729558"	"R-HSA-392499"	"Metabolism of proteins"	""	"1.0"	"Neoplastic Process (T191)"	"<span class='gene' en_id='171023'>ASXL1</span> deficiency increased resistance to <span class='chemical' en_id='C0049065'>decitabine</span> treatment in <span class='disease' en_id='C0023467'>AML</span> cell lines and mouse bone marrow cells."	"disease"	"Q498B9,Q8IXJ9"	"2024"	"C0049065"	"therapeutic"	"C0023467"	"ENSG00000171456"	"171023"	"protein-coding"	"38729558"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"IDH2"	"0.87"	"0.42"	"isocitrate dehydrogenase (NADP(+)) 2"	"0.97883"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"International journal of molecular sciences"	"509"	"4476"	"53"	"7707"	"TEXTMINING_MODELS"	"39000443"	"R-HSA-1430728,R-HSA-1852241,R-HSA-392499"	"Metabolism,Organelle biogenesis and maintenance,Metabolism of proteins"	""	"1.0"	"Neoplastic Process (T191)"	"Mutations in the genes encoding IDH1 and <span class='gene' en_id='3418'>IDH2</span> and, less commonly, IDH3 have been found in a variety of cancers, most commonly glioma, <span class='disease' en_id='C0023467'>acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>), chondrosarcoma, and intrahepatic cholangiocarcinoma."	"disease"	"B4DSZ6,P48735"	"2024"	""	""	"C0023467"	"ENSG00000182054"	"3418"	"protein-coding"	"39000443"	"PMID"
"CausalorOrContributing"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"BCL2"	"0.91"	"0.3"	"BCL2 apoptosis regulator"	"0.98901"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Journal of experimental & clinical cancer research : CR"	"1777"	"4476"	"45"	"7707"	"TEXTMINING_MODELS"	"38475919"	"R-HSA-1266738,R-HSA-162582,R-HSA-168256,R-HSA-5357801,R-HSA-8953897"	"Developmental Biology,Signal Transduction,Immune System,Programmed Cell Death,Cellular responses to stimuli"	"Signaling"	"1.0"	"Neoplastic Process (T191)"	"Our results indicate that <span class='disease' en_id='C0023467'>AML</span> patients with a low C/EBPα p42/p30 ratio (e.g., CEBPAbi) may <span class='negation_marker' en_id=''>not</span> benefit from monotherapy with <span class='gene' en_id='596'>BCL2</span> inhibitors."	"disease"	"A0A7I2V3S7,P10415"	"2024"	""	""	"C0023467"	"ENSG00000171791"	"596"	"protein-coding"	"38475919"	"PMID"
"AlteredExpression"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"TET2"	"0.91"	"0.42"	"tet methylcytosine dioxygenase 2"	"9.5545E-155"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"The Journal of clinical investigation"	"622"	"4476"	"75"	"7707"	"TEXTMINING_MODELS"	"38950330"	"R-HSA-1474165,R-HSA-74160"	"Reproduction,Gene expression (Transcription)"	""	"1.0"	"Neoplastic Process (T191)"	"These compounds show antileukemic activity against FLT3ITD in drug-resistant <span class='disease' en_id='C0023467'>AML</span>, relapsed/refractory <span class='disease' en_id='C0023467'>AML</span>, and in <span class='disease' en_id='C0023467'>AML</span> bearing a combination of epigenetic mutations of <span class='gene' en_id='54790'>TET2</span> along with FLT3ITD."	"disease"	"Q6N021,A0A158SIU0"	"2024"	""	""	"C0023467"	"ENSG00000168769"	"54790"	"protein-coding"	"38950330"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"KIT"	"0.91"	"0.31"	"KIT proto-oncogene, receptor tyrosine kinase"	"1.0"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Acta pharmacologica Sinica"	"1573"	"4476"	"978"	"7707"	"TEXTMINING_MODELS"	"38017299"	"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-74160"	"Developmental Biology,Signal Transduction,Disease,Gene expression (Transcription)"	"Kinase"	"1.0"	"Neoplastic Process (T191)"	"In this study we investigated the combination therapy of agents targeting RUNX1-RUNX1T1 and <span class='gene' en_id='3815'>KIT</span> in the treatment of t(8;21) <span class='disease' en_id='C0023467'>AML</span> with <span class='gene' en_id='3815'>KIT</span> mutations."	"disease"	"P10721"	"2024"	""	""	"C0023467"	"ENSG00000157404"	"3815"	"protein-coding"	"38017299"	"PMID"
"CausalorOrContributing"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"RUNX1"	"0.87"	"0.4"	"RUNX family transcription factor 1"	"0.28954"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"Leukemia"	"657"	"4476"	"663"	"7707"	"TEXTMINING_MODELS"	"38086946"	"R-HSA-1266738,R-HSA-162582,R-HSA-1643685,R-HSA-382551,R-HSA-74160"	"Developmental Biology,Signal Transduction,Disease,Transport of small molecules,Gene expression (Transcription)"	"Transcription factor"	"1.0"	"Neoplastic Process (T191)"	"Tegavivint (TV, BC-2059), known to disrupt the binding of nuclear β-catenin and TCF7L2/LEF1 with TBL1, also inhibited co-localization of <span class='gene' en_id='1236,2122,861'>EVI1</span> with TBL1 and dose-dependently induced apoptosis in <span class='disease' en_id='C0023467'>AML</span> cell lines and patient-derived (PD) <span class='disease' en_id='C0023467'>AML</span> cells with 3q26.2 lesions."	"disease"	"Q01196"	"2024"	""	""	"C0023467"	"ENSG00000159216"	"861"	"protein-coding"	"38086946"	"PMID"
"GeneticVariation"	""	"disease of cellular proliferation (14566),disease of anatomical entity (7)"	"Acute myeloid leukemia"	"Hemic and Lymphatic Diseases,Neoplasms"	"IDH1"	"0.91"	"0.41"	"isocitrate dehydrogenase (NADP(+)) 1"	"9.0901E-5"	"Abnormality of blood and blood-forming tissues (01871),Abnormality of the immune system (02715),Neoplasm (02664)"	"International journal of molecular sciences"	"620"	"4476"	"11"	"7707"	"TEXTMINING_MODELS"	"39000443"	"R-HSA-1430728,R-HSA-1643685,R-HSA-168256,R-HSA-8953897,R-HSA-9609507"	"Metabolism,Disease,Immune System,Cellular responses to stimuli,Protein localization"	""	"1.0"	"Neoplastic Process (T191)"	"Mutations in the genes encoding <span class='gene' en_id='3417'>IDH1</span> and IDH2 and, less commonly, IDH3 have been found in a variety of cancers, most commonly glioma, <span class='disease' en_id='C0023467'>acute myeloid leukemia</span> (<span class='disease' en_id='C0023467'>AML</span>), chondrosarcoma, and intrahepatic cholangiocarcinoma."	"disease"	"O75874,A0A024R3Y6"	"2024"	""	""	"C0023467"	"ENSG00000138413"	"3417"	"protein-coding"	"39000443"	"PMID"
